Related references
Note: Only part of the references are listed.Reproductive factors, hormone use, estrogen receptor expression and risk of non-small-cell lung cancer in women
Ann G. Schwartz et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
EGFR signaling is required for TGF-β1-Mediated COX-2 induction in human bronchial epithelial cells
Ming Liu et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2007)
Cancer mortality in the united states by education level and race
Jessica D. Albano et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
Combination therapy with gefitinib and rofecoxib in patients with platinum-pretreated relapsed non-small-cell lung cancer
Kenneth J. O'Byrne et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Prospective study of gefitinib in epidermal growth factor receptor fluorescence in situ hybridization-positive/phospho-akt-positive or never smoker patients with advanced non-small-cell lung cancer:: The ONCOBELL trial
Federico Cappuzzo et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Epidermal growth factor receptor gene copy number and protein level are not associated with outcome of non-small-cell lung cancer patients treated with chemotherapy
R. Dziadziuszko et al.
ANNALS OF ONCOLOGY (2007)
Phase II study of gefitinib, an epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI), and celecoxib, a cyclooxygenase-2 (COX-2) inhibitor, in patients with platinum refractory non-small cell lung cancer (NSCLC)
Shirish M. Gadgeel et al.
JOURNAL OF THORACIC ONCOLOGY (2007)
Combination of EGFR gene copy number and protein expression predicts outcome for advanced non-small-cell lung cancer patients treated with gefitinib
F. R. Hirsch et al.
ANNALS OF ONCOLOGY (2007)
Clinicopathologic features and prognostic implications of epidermal growth factor receptor (EGFR) gene copy number and protein expression in non-small cell lung cancer
Yoon Kyung Jeon et al.
LUNG CANCER (2006)
Molecular predictors of outcome with gefitinib in a phase III placebo-controlled study in advanced non-small-cell lung cancer
Fred R. Hirsch et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Combined analysis of cyclooxygenase-2 expression with p53 and Ki-67 in nonsmall cell lung cancer
Hiroyoshi Tsubochi et al.
ANNALS OF THORACIC SURGERY (2006)
Has Cox-2 a prognostic role in non-small-cell lung cancer? A systematic review of the literature with meta-analysis of the survival results
C. Mascaux et al.
BRITISH JOURNAL OF CANCER (2006)
A phase I trial to determine the optimal biological dose of celecoxib when combined with erlotinib in advanced non-small cell lung cancer
Karen L. Reckamp et al.
CLINICAL CANCER RESEARCH (2006)
Distinct epidermal growth factor receptor and KRAS mutation patterns in non-small cell lung cancer patients with different tobacco exposure and clinicopathologic features
IYS Tam et al.
CLINICAL CANCER RESEARCH (2006)
Cyclooxygenase-2 and epithelial growth factor receptor up-regulation during progression of Barrett's esophagus to adenocarcinoma
Yan Li et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2006)
Unlimited access to care: Effect on racial disparity and prognostic factors in lung cancer
CR Mulligan et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2006)
Total cyclooxygenase-2 mRNA levels correlate with vascular endothelial growth factor mRNA levels, tumor angiogenesis and prognosis in non-small cell lung cancer patients
A Yuan et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Epidermal growth factor receptor gene and protein and gefitinib sensitivity in non-small-cell lung cancer
F Cappuzzo et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Synchronous coexpression of epidermal growth factor receptor and cyclooxygenase-2 in carcinomas of the uterine cervix: A potential predictor of poor survival
GE Kim et al.
CLINICAL CANCER RESEARCH (2004)
COX-2, MMP-9, and Noguchi classification provide additional prognostic information about adenocarcinoma of the lung - A study of 117 patients from Brazil
NH Yamaguchi et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2004)
Prognostic factors in resected stage I non-small-cell lung cancer: A multivariate analysis of six molecular markers
C Lu et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
HER-2, EGFR, COX-2 expression status correlated to microvessel density and survival in resected non-small cell lung cancer
D Brattstrom et al.
ACTA ONCOLOGICA (2004)
Epidermal growth factor receptor in non-small-cell lung carcinomas:: Correlation between gene copy number and protein expression and impact on prognosis
FR Hirsch et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Cyclooxygenase-2 in human non-small cell lung cancer
HY Fang et al.
EUROPEAN JOURNAL OF SURGICAL ONCOLOGY (2003)
The role of EGF-R expression on patient survival in lung cancer: a systematic review with meta-analysis
AP Meert et al.
EUROPEAN RESPIRATORY JOURNAL (2002)
Outcomes among African-American/Non-African-American patients with advanced non-small-cell lung carcinoma: Report from the cancer and leukemia group B
AW Blackstock et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2002)
Influence of cigarette smoking on prostaglandin synthesis and cyclooxygenase-2 gene expression in human urinary bladder cancer
AF Badawi et al.
CANCER INVESTIGATION (2002)
The epidermal growth factor receptor family as a central element for cellular signal transduction and diversification
N Prenzel et al.
ENDOCRINE-RELATED CANCER (2001)
Increased cyclooxygenase 2 (COX-2) expression occurs frequently in precursor lesions of human adenocarcinoma of the lung
Y Hosomi et al.
LUNG CANCER (2000)
Share Paper
